Submission to the College of Physicians and Surgeons of Ontario Regarding Medical Assistance in Dying

A user is advocating for Phase 3 trials of the hair loss treatment PP405 to be conducted in Germany, citing benefits like a diverse patient base and faster access for European patients. Despite skepticism about the petition's influence, the user believes it can demonstrate significant interest and potentially influence strategic decisions.

The conversation discusses the importance of Finasteride for hair loss treatment in the EU and encourages individuals to voice their support to the EMA. It highlights the potential influence of public input on regulatory decisions.

A user is seeking information on clinics in Toronto offering dutasteride mesotherapy as an alternative to oral dutasteride while trying to conceive. They are looking for recommendations and information.

A user from Ontario, Canada, is seeking cheaper options for topical Minoxidil and oral Finasteride for hair loss, as current prices are around $300 for a three-month supply. They are asking if this pricing is typical and if there are more affordable alternatives.

People in Canada are using telehealth platforms like Felix, Phoenix, and Essential to access oral minoxidil and finasteride for hair loss treatment. Some users report satisfaction with these services, while others caution about potential side effects or issues with mixing medications.

A user is seeking advice on obtaining oral minoxidil in Australia through telehealth services. They are considering options like Mosh and are unsure if they should mention previous use or claim it's for hypertension.